Attorney Authored
Myriad Case May Shape The Future Of Medical Patents
July 20, 2012
By GERALD FLATTMAN
In this article, appearing on Forbes.com, Gerald Flattman discusses how a broad application of the Mayo decision would be disruptive to both the legal industry and the pharmaceutical and biotech industries.